|
Volumn 1, Issue 3, 2003, Pages 216-218
|
Trends and treatment of heart failure developing after acute myocardial infarction.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALDOSTERONE ANTAGONIST;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
CARDIOLOGY;
COMORBIDITY;
CONGESTIVE HEART FAILURE;
HEART INFARCTION;
HUMAN;
INCIDENCE;
METHODOLOGY;
REVIEW;
RISK FACTOR;
TREATMENT OUTCOME;
UNITED STATES;
ADRENERGIC BETA-ANTAGONISTS;
ALDOSTERONE ANTAGONISTS;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
CARDIOLOGY;
COMORBIDITY;
HEART FAILURE, CONGESTIVE;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
INCIDENCE;
MYOCARDIAL INFARCTION;
RISK FACTORS;
TREATMENT OUTCOME;
UNITED STATES;
|
EID: 16244411940
PISSN: 15419215
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1541-9215.2003.02621.x Document Type: Review |
Times cited : (2)
|
References (30)
|